One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Orthobiologics Market

[ 英語タイトル ] Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022


Product Code : MNMHC00108822
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The orthobiologics market projected to grow at a CAGR of 5.4%.”
The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. However, high cost pertaining to orthobiologics based treatment is the major factor restraining the market growth to a certain extent.

“The PRP segment is expected to grow at the highest rate during the forecast period.”
The PRP market is expected to grow at the highest CAGR during the forecast period. The advantages of PRP (such as reduced hospital stay) over other products used in bone stimulation are expected to drive the growth of this market. Additionally, the increasing use of PRP in sports injuries and the growing number of clinical trials to expand the application areas of PRP are expected to support the growth of this market during the forecast period.

“The spinal fusion segment is expected to grow at the highest CAGR.”
Based on applications, the orthobiologics market has been categorized into the following segments: fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. Amongst these, the spinal fusion segment is expected to grow at highest CAGR during the forecast period owing to factors such as the rising number of spinal fusion procedures, increasing adoption of allografts & BMAC as part of adjuvant therapy during spinal fusion procedures, & extensive use of stem cells for bone regeneration and bone grafting procedures.
“Hospitals, orthopedic clinics, and ambulatory care centers are expected to be the fastest-growing segment.”
On the basis of end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers; research & academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period. This can be attributed to the growing geriatric population (coupled with the increasing number of spinal fusion surgeries performed); road accident injuries and bone fractures; growing prevalence of spinal disorders; and growing awareness of products.

“Asia Pacific is expected to register the highest growth rate in the orthobiologics market.”
Geographically, the orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific market is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.

Breakdown of supply-side primary interviews:
• By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – – C-level – 26%, Director level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%

The major players in the market included are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, and Globus Medical.

Research Coverage

This report studies the orthobiologics market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the orthobiologics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKETS COVERED 14
1.3.1 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 RESEARCH LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.1.1 SECONDARY DATA 17
2.1.2 PRIMARY DATA 18
2.2 MARKET SIZE ESTIMATION METHODOLOGY 19
2.2.1 BOTTOM-UP APPROACH 19
2.2.2 TOP-DOWN APPROACH 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.4 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 GLOBAL ORTHOBIOLOGICS MARKET OVERVIEW 27
4.2 GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT (2017 VS. 2022) 28
4.3 ORTHOBIOLOGICS MARKET: REGIONAL ANALYSIS (2017–2022) 29
4.4 ORTHOBIOLOGICS MARKET: BY APPLICATION, 2017 30
4.5 GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 MARKET DRIVERS 33
5.2.1.1 Increasing incidence of sports injuries and road accidents 33
5.2.1.2 Increasing incidence of spinal diseases/disorders 34
5.2.1.3 Rising geriatric and obese population 34
5.2.1.4 Growing patient preference for minimally invasive procedures 35
5.2.2 MARKET RESTRAINT 36
5.2.2.1 High cost associated with orthobiologics-based treatments 36
5.2.3 GROWTH OPPORTUNITIES 36
5.2.3.1 Emerging markets 36
5.2.3.2 Increasing use of PRP in other applications 37
5.2.4 MARKET CHALLENGES 37
5.2.4.1 Lawsuits filed against major market players affecting their brand value 37
5.2.4.2 Side effects associated with BMP-based treatments 37
5.3 KEY INDUSTRY TREND 38
6 ORTHOBIOLOGICS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 VISCOSUPPLEMENTATION PRODUCTS 41
6.3 DEMINERALIZED BONE MATRICES 42
6.4 SYNTHETIC ORTHOBIOLOGICS 43
6.5 BONE MORPHOGENIC PROTEIN 44
6.6 ALLOGRAFTS 45
6.7 PLASMA-RICH PROTEIN 46
6.8 BONE MARROW ASPIRATE CONCENTRATE 47
7 ORTHOBIOLOGICS MARKET, BY APPLICATION 48
7.1 INTRODUCTION 49
7.2 OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS 50
7.3 SPINAL FUSION 51
7.4 SOFT-TISSUE INJURIES 52
7.5 FRACTURE RECOVERY 53
7.6 MAXILLOFACIAL AND DENTAL APPLICATIONS 54
8 ORTHOBIOLOGICS MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOSPITALS, ORTHOPEDIC CLINICS, & AMBULATORY CARE CENTERS 57
8.3 RESEARCH & ACADEMIC INSTITUTES 58
8.4 DENTAL CLINICS AND FACILITIES 59
9 ORTHOBIOLOGICS MARKET, BY REGION 60
9.1 INTRODUCTION 61
9.2 NORTH AMERICA 62
9.2.1 US 65
9.2.2 CANADA 67
9.3 EUROPE 69
9.3.1 GERMANY 72
9.3.2 FRANCE 74
9.3.3 UK 75
9.3.4 SPAIN 77
9.3.5 ITALY 78
9.3.6 REST OF EUROPE 80
9.4 ASIA PACIFIC 81
9.4.1 JAPAN 85
9.4.2 CHINA 86
9.4.3 INDIA 87
9.4.4 REST OF ASIA PACIFIC 89
9.5 REST OF THE WORLD 91
10 COMPETITIVE LANDSCAPE 95
10.1 GLOBAL ORTHOBIOLOGICS MARKET RANKING, 2016 95
11 COMPANY PROFILES 96
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON & JOHNSON) 96
11.2 MEDTRONIC PLC. 100
11.3 STRYKER CORPORATION 103
11.4 ZIMMER BIOMET HOLDINGS, INC. 106
11.5 HARVEST TECHNOLOGIES CORPORATION (A TERUMO BCT COMPANY) 111
11.6 GLOBUS MEDICAL, INC. 114
11.7 ORTHOFIX INTERNATIONAL N.V. 117
11.8 RTI SURGICAL, INC. 120
11.9 K2M GROUP HOLDINGS, INC. 126
11.10 KUROS BIOSCIENCES LTD. 129
11.11 BIOVENTUS LLC 132
11.12 NUVASIVE, INC. 135
11.13 SEASPINE HOLDINGS CORPORATION 138
11.14 ARTHREX, INC. 141
11.15 XTANT MEDICAL HOLDINGS, INC. 144
*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 148
12.1 DISCUSSION GUIDE 148
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 153
12.4 AVAILABLE CUSTOMIZATIONS 154
12.5 RELATED REPORTS 155
12.6 AUTHOR DETAILS 156

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+